IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 909 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
 # Next article
 # Previous article 
 # Table of Contents
  
 Resource links
 #  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
 #  Article in PDF (66 KB)
 #  Citation Manager
 #  Access Statistics
 #  Reader Comments
 #  Email Alert *
 #  Add to My List *
* Registration required (free)  


  In this article

 Article Access Statistics
    Viewed2343    
    Printed38    
    Emailed0    
    PDF Downloaded60    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 
LETTER TO EDITOR
Year : 2003  |  Volume : 69  |  Issue : 4  |  Page : 314--315
 

Response by the author


Department of Skin & STD, Kasturba Medical College, Manipal - 576119

Correspondence Address:
Department of Skin & STD, Kasturba Medical College, Manipal - 576119
Office.kmc@manipal.edu



How to cite this article:
Balachandran C. Response by the author . Indian J Dermatol Venereol Leprol 2003;69:314-5


How to cite this URL:
Balachandran C. Response by the author . Indian J Dermatol Venereol Leprol [serial online] 2003 [cited 2019 Jun 27];69:314-5. Available from: http://www.ijdvl.com/text.asp?2003/69/4/314/5011


I appreciate the keen interest shown by Dr. Ramji Gupta in our article 'Treatment of pemphigus'.

1. I agree that there are only 25 references. Reference number 4 in the text should be 3, reference number 5 should be 4 and so on. I regret this error.

2. Regarding the second question, I have not made any such comment in the text.

I would like to mention that the current dexamethasone-cyclophosphamide pulse regimen is not final and needs modifications. There are now various centers in India using it, but there is no uniformity. With our vast experience in pulse therapy, we should evolve a modified uniform regimen.

3. It is better to give a slow infusion for 3-4 hours, as there is a risk of cardiac toxicity with rapid steroid infusion.

4. We have been following this regimen for many years now. We have had two deaths due to septicemia in phase 1 in spite of the patient being on antibiotics. Hence, infection is an important complication that should be appropriately treated.

The majority of patients respond within 4 pulses in the first stage and require about 6 pulses in the second stage. We also had patients who required about 24 pulses for remission. A few patients also had relapsed during the third phase. But overall this is an acceptable treatment modality.

5. I did not add many Indian references regarding pulse therapy as there were no new messages to convey.
 

 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow